207 related articles for article (PubMed ID: 31354258)
1. Effects of long-term macrolide therapy at low doses in stable COPD.
Cao Y; Xuan S; Wu Y; Yao X
Int J Chron Obstruct Pulmon Dis; 2019; 14():1289-1298. PubMed ID: 31354258
[No Abstract] [Full Text] [Related]
2. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis.
Cui Y; Luo L; Li C; Chen P; Chen Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():3813-3829. PubMed ID: 30538443
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
5. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
Trials; 2012 Jun; 13():82. PubMed ID: 22682323
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis.
Ni W; Shao X; Cai X; Wei C; Cui J; Wang R; Liu Y
PLoS One; 2015; 10(3):e0121257. PubMed ID: 25812085
[TBL] [Abstract][Full Text] [Related]
7. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
[TBL] [Abstract][Full Text] [Related]
8. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
[TBL] [Abstract][Full Text] [Related]
9. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
[TBL] [Abstract][Full Text] [Related]
10. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis.
Yao GY; Ma YL; Zhang MQ; Gao ZC
Respiration; 2013; 86(3):254-60. PubMed ID: 23817204
[TBL] [Abstract][Full Text] [Related]
11. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Simoens S; Laekeman G; Decramer M
Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
[TBL] [Abstract][Full Text] [Related]
12. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD.
Wang JX; Li HQ; Zhang F; Ning W
Int J Chron Obstruct Pulmon Dis; 2019; 14():1923-1932. PubMed ID: 31692553
[TBL] [Abstract][Full Text] [Related]
14. Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
Ramos FL; Criner GJ
Curr Opin Pulm Med; 2014 Mar; 20(2):153-8. PubMed ID: 24378875
[TBL] [Abstract][Full Text] [Related]
15. Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis.
Yan M; Saxena FE; Calzavara A; Brown KA; Garber G; Gershon AS; Johnstone J; Kumar M; Langford BJ; Lee S; Schwartz KL; Daneman N
CMAJ Open; 2021; 9(2):E576-E584. PubMed ID: 34021016
[TBL] [Abstract][Full Text] [Related]
16. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
[TBL] [Abstract][Full Text] [Related]
17. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
[TBL] [Abstract][Full Text] [Related]
18. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Wang Y; Zijp TR; Bahar MA; Kocks JWH; Wilffert B; Hak E
J Antimicrob Chemother; 2018 Dec; 73(12):3231-3243. PubMed ID: 30189002
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
